Schonfeld Strategic Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-220,000	Closed	-$4.08M	–	2354
2023 Q3	$4.08M	Buy	+220,000	New	+$2.49M	0.03%	606
2017 Q4	–	Sell	-30,000	Closed	-$103K	–	924
2017 Q3	$103K	Buy	+30,000	New	+$3.23M	0.01%	540

Schonfeld Strategic Advisors's ICPT Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2022, closing a stake of 50,503 shares — an estimated $705K sold.

Schonfeld Strategic Advisors first reported a position in ICPT in Q4 2016 and held it in 10 quarters. The position peaked at $2.14M in Q3 2019. 144 funds tracked by Wall St. Rank hold ICPT as of Q4 2022.

Schonfeld Strategic Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 50,503 Intercept Pharmaceuticals, Inc. shares in Q4 2022, an estimated $705K.
Schonfeld Strategic Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2016 and held it in 10 quarters.
Schonfeld Strategic Advisors's Intercept Pharmaceuticals, Inc. position peaked at $2.14M in Q3 2019.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.